Taken together, our results, along with previous findings, suggest a clear selectivity of CA-4 cytotoxicity toward tumor cells compared to non-dividing healthy lymphocytes, with proliferating lymphocytes being more sensitive. The gene discussed is CA4; the disease is neoplasm.